van der Ploeg, AT
16  Ergebnisse:
Personensuche X
?
2

Modeling cartilage pathology in mucopolysaccharidosis VI us..:

Broeders, M. ; van Rooij, Jgj ; Oussoren, E....
Frontiers in Bioengineering and Biotechnology.  10 (2022)  - p. , 2022
 
?
4

P.025 Efficacy and safety results of the avalglucosidase al..:

Tarnopolsky, M ; Attarian, S ; Borges, J...
Canadian Journal of Neurological Sciences / Journal Canadien des Sciences Neurologiques.  48 (2021)  s3 - p. S27-S27 , 2021
 
?
 
?
7

Neurocognitive outcome and mental health in children with t..:

van Vliet, K ; van Ginkel, WG ; Jahja, R...
https://discovery.ucl.ac.uk/id/eprint/10152449/1/J%20of%20Inher%20Metab%20Disea%20-%202022%20-%20Vliet%20-%20Neurocognitive%20outcome%20and%20mental%20health%20in%20children%20with%20tyrosinemia%20type%201%20and.pdf.  , 2022
 
?
 
?
9

Childhood Pompe disease: clinical spectrum and genotype in ..:

van Capelle, CI ; van der Meijden, JC ; van den Hout, JMP...
https://discovery.ucl.ac.uk/id/eprint/10050771/1/s13023-016-0442-y.pdf.  , 2016
 
?
 
?
11

Lung MRI and impairment of diaphragmatic function in Pompe ..:

Wens SCA ; Ciet P ; Perez-Rovira A...
info:eu-repo/semantics/altIdentifier/pmid/25943437.  , 2015
 
?
 
?
13

Mucopolysaccharidosis type II (Hunter syndrome): a clinical..:

WRAITH JE ; BECK M ; BODAMER OA...
info:eu-repo/semantics/altIdentifier/wos/WOS:000252991400002.  , 2008
 
?
15

Modeling cartilage pathology in mucopolysaccharidosis VI us..:

M. Broeders ; Jgj van Rooij ; E. Oussoren...
https://www.frontiersin.org/articles/10.3389/fbioe.2022.949063/full.  , 2022
 
1-15